An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

Basit Öğe Kaydı
dc.authoridSevindik, Omur Gokmen/0000-0001-9636-4113
dc.authoridmaral, senem/0000-0003-4766-1861
dc.authoridKirkizlar, Onur/0000-0001-7523-8599
dc.authoridipek, yildiz/0000-0003-2952-2286
dc.authorwosidKALAYOGLU BESİSİK, SEVGİ/HNO-9101-2023
dc.authorwosidSaydam, Guray/W-3827-2017
dc.authorwosidSevindik, Omur Gokmen/AAD-5452-2021
dc.authorwosidSalihoglu, Ayse/Y-8937-2018
dc.authorwosidmaral, senem/AAH-9926-2021
dc.authorwosidKirkizlar, Onur/W-9594-2018
dc.authorwosidipek, yildiz/ACY-2160-2022
dc.contributor.authorSevindik, Omur Gokmen
dc.contributor.authorOzkurt, Zubeyde Nur
dc.contributor.authorBoga, Can
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorIpek, Yildiz
dc.contributor.authorGeduk, Ayfer
dc.contributor.authorHarmandali, Aybuke
dc.date.accessioned2024-06-12T11:24:08Z
dc.date.available2024-06-12T11:24:08Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS103en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.startpageS102en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26827
dc.identifier.volume21en_US
dc.identifier.wosWOS:000717640800179en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAn interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu